- $394.89bn
- $458.00bn
- $56.33bn
- 97
- 44
- 84
- 88
REG - Legg Mason, Inc. AbbVie Inc. - Form 8.3 - Allergan PLC
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE INC
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(a) - AbbVie Inc
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(a) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5(b) - AbbVie Inc
AnnouncementREG-BARCLAYS PLC FORM 8.3 - ABBVIE INC - Amendment
AnnouncementREG-BARCLAYS PLC FORM 8.3 - ABBVIE PLC
AnnouncementREG-BARCLAYS PLC Form 8.3 - ABBVIE INC - AMENDMENT
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - [AbbVie Inc]
AnnouncementREG-TIAA-CREF Form 8.3 - AbbVie Inc.
AnnouncementREG - BkofA Merrill Lynch AbbVie Inc. - Form 38.5 (b) - AbbVie Inc
Announcement